Rocephin:医薬品の世界市場規模、市販状況、特許、APIメーカー分析2014

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DID2014API236)
◆英語タイトル:Rocephin-API Insights, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DID2014API236
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(納品まで約3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD500 ⇒換算¥55,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD1,000 ⇒換算¥110,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Rocephin:医薬品の世界市場規模、市販状況、特許、APIメーカー分析2014]についてメールでお問い合わせはこちら
当調査レポートでは、Rocephin医薬品市場について調査・分析し、医薬品の概要、世界販売量予測、作用機序、薬力学的特性、薬物動態学的特性、アメリカ及びヨーロッパでの市販状況、特許情報、世界各地域別APIメーカー分析情報などを以下の構成でお届けいたします。※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。

・医薬品の概要
・世界販売量予測データ
・医薬品の説明
・作用機序(MOA)
・薬力学的特性
・薬物動態学的特性
・市販状況:アメリカ、ヨーロッパ
・特許情報
・特許権及び独占権(Exclusivity)存続期間
・グローバルAPIメーカー:地域別分析
・企業概要
*** レポート概要(サマリー)***

Summary

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.
India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing ‘Process Validation: General Principles and Practices’. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China.

DelveInsight’s, Rocephin -API Insights, 2014 Report provides marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drug. It also provides the India and China API Manufactures who are driving the current API Market. The report also highlights the patent, patent exclusivity information and competitive landscape. The research, analysis also presents the global sales forecasts data till 2015.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.


Scope

• A review of the Rocephin based on information derived from company and industry-specific sources
• Coverage of the Marketed data of the Rocephin on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
• Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for drug with location details.
• Patent Expiry Timeline and Exclusivity Details
• Global Forecasted Sales Figure from 2011-2015
• Qualitative and quantitative assessment of market space

*** レポート目次(コンテンツ)***

Table of Contents

• Drug Overview
• Global Sales Assessment
• Product Description
• Mechanism of Action
• Pharmacodynamic Properties
• Pharmacokinetic Properties
• Marketed Details for the United States
• Marketed Details for the Europe
• Patent Information
• Patent and Exclusivity Expiry Assessment United States (US)
• Patent Numbers and Expiry Details
• Patent Details
• Global API Manufacturers Assessment
• The United States Drug Master File (US DMF)
• The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
• The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
• The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status
• The Active Pharmaceutical Ingredient (API) Manufacturers by Region
• The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
• Generic Players
• Company Profile
• Summary
• Company Financials
• References
• Appendix
• Methodology
• About DelveInsight
• Contact Us
• Disclaimer

List of Tables
• Rocephin, Market, Global Sales (in USD), 2014
• Rocephin, Description
• Rocephin, Marketed Details the United States (US)
• Rocephin, Marketed Details the Europe (EU)
• Rocephin, Patent/Exclusivity Expiry (Year), 2014
• Rocephin, Patent Number Specific Patent Expiry (Year), 2014
• Rocephin, Patent Details
• Rocephin, the United States Drug Master File (US DMF), 2014
• Rocephin, the Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF), 2014
• Rocephin, the API Manufacturers, China, 2014
• Rocephin, the API Manufacturers, India, 2014
• Rocephin, the API Manufacturers by the US DMF Status, 2014
• Rocephin, the API Manufacturers by Region, 2014
• Rocephin, the API Manufacturers by Location/Countries, 2014
• Rocephin, Generic Players, 2014
• Company Overview, 2014

List of Figures
• Rocephin, Market, Global Sales (in million USD), 2014
• Rocephin, Global Sales % Change, 2014
• Rocephin, Patent/Exclusivity Expiry (Year), 2014
• Rocephin, Patent Number Specific Patent Expiry (Year), 2014
• Rocephin, the API Manufacturers by the US DMF Status (%), 2014
• Rocephin, the API Manufacturers by Region, 2014
• Rocephin, the API Manufacturers by Location/Countries, 2014
• Rocephin, Generic Players, 2014

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • Cable & Wireless Communications Plc:企業概要、財務・SWOT分析
    Cable & Wireless Communications Plc Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Cable & Wireless Communications Plc annual and quarterly forecasts made by stock market ex …
  • 末端肥大症・巨人症治療薬の世界市場2018-2022:ソマトスタチン類縁体、GH受容体遮断薬、ドパミン受容体刺激薬、組換えヒトIGF-1
    About Acromegaly and Gigantism DrugsThe acromegaly and gigantism are GH-related diseases. Acromegaly disease occurs in adults while gigantism occurs in children. Technavio’s analysts forecast the global acromegaly and gigantism drugs market to grow at a CAGR of 3.03% during the period 2018-2022. [Co …
  • 世界の化学薬品の生薬市場2016
    2016 Global Chemical Raw Medicine Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Chemical Raw Medicine industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan …
  • 研磨ロボットの世界市場2018-2022:自動車、金属・機械、航空宇宙・防衛、その他
    This market research report presents a comprehensive analysis of the global grinding robots market based on end-user (automotive sector, metal and machinery sector, aerospace and defense sector, and others) and solution (software, services, and hardware). The report also provides an analysis of the …
  • 世界の癌治療用モノクローナル抗体市場及びパイプライン分析
    Recent years have witnessed the emergence of monoclonal antibodies, which has the potential to offer less toxic and more efficient therapeutic alternatives for patients. Over the past decades, the researchers have increased their learning about the human body’s immune system, which has led to the ac …
  • フェロボロンの世界市場
    Ferroboron (CAS 11108-67-1) Market Research Report 2014 presents comprehensive data on ferroboron markets globally and regionally (Europe, Asia, North America etc.) The report includes ferroboron description, covers its application areas and related patterns. It overviews ferroboron market, names fe …
  • モベイス(MOBASE Co., Ltd.)の企業概要及び財務データ:韓国企業調査レポート
    韓国企業の概要及び財務データをまとめたレポートです。該当企業の設立日、住所、社員数、資本金、事業分野、連絡先、企業格付などの概要と、最近3年間の会計年度別貸借対照表(B/S)、損益計算書(P/L)、キャッシュ・フロー計算書(C/F)など財務データを調査しました。 韓国企業と取引する時、韓国に進出を検討する時、或いは韓国の競合企業を調べる時に、本データをご活用ください。追加のデータや詳しい情報が必要な場合は別途カスタムリサーチ(委託調査)サービスで対応致します。
  • ICT支出予測(中規模企業):カナダ医療・ヘルスケア産業部門 – ICT予算内訳予測
    Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model that provides ICT spending predictions based on a company’s demographic profile. The statistical model has been developed using an extensive collection of su …
  • B型肝炎ウイルス(HBV)に対する治療薬の世界市場2018
    Hepatitis B Virus [HBV] Treatment Report by Material, Application, and Geography – Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (Uni …
  • 世界及び中国の1カリウムリン酸塩市場2016
    The 'Global and Chinese Monopotassium Phosphate Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Monopotassium Phosphate industry with a focus on the Chinese market. The report provides key statistics on the market status of the Mono …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DID2014API236 )"Rocephin:医薬品の世界市場規模、市販状況、特許、APIメーカー分析2014" (英文:Rocephin-API Insights, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。